The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies
Abstract
Microparticulate delivery systems designed for the nasal administration of an antiemetic drug, metoclopramide hydrochloride, were prepared. Microspheres composed of sodium alginate, chitosan hydrochloride, or both, were obtained using a spray-drying method; some batches of drug-free microparticles were prepared as a comparison. The morphology, in-vitro swelling behaviour, mucoadhesive properties and drug release from microparticles were evaluated. Ex-vivo drug permeation tests were carried out using sheep nasal mucosa; permeation test of the drug solution was peformed as comparison. During ex-vivo permeation tests, transmission electron microscopy (TEM) analyses were carried out on the nasal mucosa to study the morphological changes of epithelial cells and tight junctions, while the change in microsphere morphology was examined using photostereo microscopy (PM). Spray-dried microparticles had a mean diameter (dvs) in the range of about 3–10 μm. They showed good in-vitro mucoadhesive properties. In-vitro release profiles and swelling behaviour depended on their composition: the drug release occurred in 1–3 h. Ex-vivo studies showed that drug permeation through the mucosa from microparticles based on chitosan was higher than from those consisting of alginate alone. This can be related to the penetration enhancing properties of chitosan. Complexation of chitosan with alginate led to a control of the drug release. Microscopy observation of microspheres during the permeation tests revealed that microparticles swelled and gelled, maintaining their shape. TEM analyses of the mucosa after exposure to the microparticles consisting of alginate/chitosan showed opened tight junctions. This preliminary study shows that alginate/chitosan spray-dried microspheres have promising properties for use as mucoadhesive nasal carriers of an antiemetic drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the negative charge of the sialic acid, sulfate groups on the oligosaccharide chains of mucins and surrounding anions aid gel formation as well as they enhance the association in the mucus layer and subsequent internalization via endocytosis of CSNPs.133”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [133]
Citations
Cites
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Research works printed but not linked: 28
- Borchard, 2001, Modern drug delivery applications of chitosan, Adv. Drug Del. Rev., 52, 103, 10.1016/S0169-409X(01)00188-0 · DOI
- Conte, 1994, Spray dried albumin microspheres containing nicardipine, Eur. J. Pharm. Biopharm., 40, 203
- Dondeti, 1996, Bioadhesive and formulation parameters affecting nasal absorption, Int. J. Pharm., 127, 115, 10.1016/0378-5173(95)04115-X · DOI
- Edmundson, 1967, Advances in pharmaceutical sciences 2, 950
- El-Gindy, 2003, Spectrophotometric and LC determination of two binary mixtures containing pyridoxine hydrochloride, J. Pharm. Biomed. Anal., 32, 277, 10.1016/S0731-7085(03)00051-7 · DOI
- El-Sayed, 1995, In vivo evaluation of sustained-release of metoclopramide hydrochloride in beagle dogs, Int. J. Pharm., 123, 113, 10.1016/0378-5173(95)00054-M · DOI
- Giunchedi, 1995, Spray-drying as a preparation method of microparticulate drug delivery systems: an overview, S.T.P. Pharma Sci., 5, 276
- Giunchedi, 2000, Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method, J. Microencapsul., 17, 711, 10.1080/02652040050161701 · DOI
- Gombotz, 1998, Protein release from alginate matrices, Adv. Drug Del. Rev., 31, 267, 10.1016/S0169-409X(97)00124-5 · DOI
- Gupta, 2002, Hydrogels: from controlled release to pH-responsive drug delivery, Drug Discov. Today, 7, 569, 10.1016/S1359-6446(02)02255-9 · DOI · Paper page
- He, 1998, In vitro evaluation of mucoadhesive properties of chitosan microspheres, Int. J. Pharm., 166, 75, 10.1016/S0378-5173(98)00027-1 · DOI
- Hussain, 1998, Intranasal drug delivery, Adv. Drug Del. Rev., 29, 39, 10.1016/S0169-409X(97)00060-4 · DOI
- Illum, 1999, Bioadhesive formulations for nasal peptide delivery, 507
- Illum, 2003, Nasal drug delivery — possibilities, problems and solutions, J. Control. Release, 87, 187, 10.1016/S0168-3659(02)00363-2 · DOI
- Kraut, 2001, Anti-emetics for cancer chemotherapy-induced emesis — potential of alternative delivery systems, Drugs, 61, 1553, 10.2165/00003495-200161110-00003 · DOI
- Lim, 2000, Preparation and evaluation of the in vitro drug release properties of novel microspheres of hyaluronic acid and chitosan, J. Control. Release, 66, 281, 10.1016/S0168-3659(99)00285-0 · DOI
- Liu, 1997, Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres, J. Control. Release, 43, 65, 10.1016/S0168-3659(96)01471-X · DOI
- Lucinda-Silva, 2003, Microspheres of alginate-chitosan containing isoniazid, J. Microencapsul., 20, 145, 10.3109/02652040309178057 · DOI
- Nordby, 2003, Thermoreversible gelation of aqueous mixture of pectin and chitosan, Biomacromulecules, 4, 337, 10.1021/bm020107+ · DOI
- O'Hogan, 1990, Nasal absorption enhancers for biosynthetic human growth hormone in rats, Pharm. Res., 7, 772, 10.1023/A:1015884026056 · DOI
- Reardon, 1993, Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro, Pharm. Res., 10, 1301, 10.1023/A:1018965612638 · DOI
- Sinha, 2004, Chitosan microspheres as a potential carrier for drugs, Int. J. Pharm., 274, 1, 10.1016/j.ijpharm.2003.12.026 · DOI
- Soane, 1999, Evaluation of the clearance characteristics of bioadhesive systems in humans, Int. J. Pharm., 178, 55, 10.1016/S0378-5173(98)00367-6 · DOI
- Uchido, 1991, Influence of bile salts on the permeability of insulin through the nasal mucosa of rabbits in comparison with dextran derivatives, Int. J. Pharm., 74, 95, 10.1016/0378-5173(91)90226-E · DOI
- Ugwoke, 1999, Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits, Eur. J. Pharm. Biopharm., 9, 213
- Ugwoke, 1999, Nasal mucoadhesive drug delivery systems of the anti-parkinson drug apomorphine: influence of drug loading on in vitro and in vivo release in rabbits, Int. J. Pharm., 181, 125, 10.1016/S0378-5173(99)00018-6 · DOI
- Wadell, 1999, Nasal drug-delivery evaluation of an in vitro model using porcine nasal mucosa, Eur. J. Pharm. Sci., 7, 197, 10.1016/S0928-0987(98)00023-2 · DOI
- Wang, 2001, Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres, J. Control. Release, 73, 223, 10.1016/S0168-3659(01)00288-7 · DOI
Cited by
Sorted by citations
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.030 · Cited by 289
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
Rassu, G., Soddu, E., Cossu, M., Gavini, E., Giunchedi, P., & Dalpiaz, A. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.05.002 · Cited by 87
Self-citationGavini, E., Rassu, G., Ferraro, L., Beggiato, S., Alhalaweh, A., Velaga, S., Marchetti, N., Bandiera, P., Giunchedi, P., & Dalpiaz, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.010 · Cited by 62
Self-citationYalcin, A., Soddu, E., Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Armagan, G., Rassu, G., Gavini, E., & Giunchedi, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.017 · Cited by 37
Self-citationLangasco, R., Tanrıverdi, S. T., Özer, Ö., Roldo, M., Cossu, M., Rassu, G., Giunchedi, P., & Gavini, E. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1395458 · Cited by 25
Self-citation
Metadata
- Authors
- Gavini, E., Rassu, G., Sanna, V., Cossu, M., & Giunchedi, P.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-01
- Volume
- 57
- Issue
- 3
- Pages
- 287-294
- ISSN
- 0022-3573
- 2042-7158
- Cited by
- 114
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review